{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:11:23Z","timestamp":1785899483962,"version":"3.56.0"},"reference-count":8,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Acquired von Willebrand disease (aVWD) is a rare disorder associated with a reduction in von Willebrand factor (VWF) activity, leading to increased bleeding risk. Monoclonal gammopathy of undetermined significance (MGUS) is the most common cause of lymphoproliferative disorder-associated aVWD and is caused by accelerated clearance of circulating VWF. Standard VWF replacement protocols for congenital VWD based on intermittent bolus dosing are typically less effective for aVWD because of antibody-mediated clearance. Intermittent bolus dosing of VWF concentrates often leads to inadequate peak response and profoundly shortened VWF half-life in aVWD. Intravenous immune globulin (IVIG) has demonstrated efficacy in aVWD; however, treatment effect is delayed up to 4 days, limiting its efficacy in acutely bleeding patients. We report the successful use of continuous-infusion VWF concentrate (with or without concomitant IVIG) in 3 patients with MGUS-associated aVWD who had demonstrated an inadequate response to bolus dosing. VWF concentrate doses required in this cohort were higher than typical doses for bleeding treatment in congenital VWD. This report illustrates that continuous-infusion VWF concentrate administration with or without intravenous immunoglobulin rapidly achieves target ristocetin cofactor activity and provides adequate hemostasis in aVWD associated with immunoglobulin G MGUS.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004843","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T15:34:50Z","timestamp":1626449690000},"page":"2813-2816","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease"],"prefix":"10.1182","volume":"5","author":[{"given":"Kathryn E.","family":"Dane","sequence":"first","affiliation":[{"name":"Department of Pharmacy and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Lindsley","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kickler","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-3493","authenticated-orcid":false,"given":"Michael B.","family":"Streiff","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8673-4317","authenticated-orcid":false,"given":"Alison","family":"Moliterno","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Yui","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Naik","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"issue":"25","key":"2021071615344881200_B1","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede","year":"2011","journal-title":"Blood."},{"issue":"8","key":"2021071615344881200_B2","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","article-title":"Acquired von Willebrand syndrome: focused for hematologists","volume":"105","author":"Franchini","year":"2020","journal-title":"Haematologica."},{"issue":"2","key":"2021071615344881200_B3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/rth2.12481","article-title":"Acquired von Willebrand syndrome in monoclonal gammopathy - a scoping review on hemostatic management","volume":"5","author":"Abou-Ismail","year":"2021","journal-title":"Res Pract Thromb Haemost."},{"issue":"8","key":"2021071615344881200_B4","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","article-title":"Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches","volume":"92","author":"Federici","year":"1998","journal-title":"Blood."},{"issue":"1","key":"2021071615344881200_B5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.10074","article-title":"Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion","volume":"70","author":"Frank","year":"2002","journal-title":"Am J Hematol."},{"issue":"6","key":"2021071615344881200_B6","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.ajog.2004.09.020","article-title":"Acquired von Willebrand disease: management of labor and delivery with intravenous dexamethasone, continuous factor concentrate, and immunoglobulin infusion","volume":"192","author":"Lipkind","year":"2005","journal-title":"Am J Obstet Gynecol."},{"issue":"6","key":"2021071615344881200_B7","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1111\/hae.12520","article-title":"Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand disease","volume":"20","author":"Patel","year":"2014","journal-title":"Haemophilia."},{"issue":"2","key":"2021071615344881200_B8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-0037-1614448","article-title":"Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease","volume":"81","author":"Lubetsky","year":"1999","journal-title":"Thromb Haemost."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/14\/2813\/1813930\/advancesadv2021004843.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/14\/2813\/1813930\/advancesadv2021004843.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T15:35:00Z","timestamp":1626449700000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/14\/2813\/476377\/Continuous-infusion-von-Willebrand-factor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":8,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,7,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004843","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]}}}